BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25944003)

  • 1. Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model.
    Tagliamonte M; Petrizzo A; Napolitano M; Luciano A; Arra C; Maiolino P; Izzo F; Tornesello ML; Aurisicchio L; Ciliberto G; Buonaguro FM; Buonaguro L
    Cancer Immunol Immunother; 2015 Oct; 64(10):1305-14. PubMed ID: 25944003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in cancer vaccine development for hepatocellular carcinoma.
    Buonaguro L; Petrizzo A; Tagliamonte M; Tornesello ML; Buonaguro FM
    J Hepatol; 2013 Oct; 59(4):897-903. PubMed ID: 23714157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
    Yang WT; Wu LW; Tseng TC; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Liu CJ; Kao JH
    Medicine (Baltimore); 2016 Mar; 95(10):e2995. PubMed ID: 26962809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.
    Di Bisceglie AM; Simpson LH; Lotze MT; Hoofnagle JH
    J Clin Gastroenterol; 1994 Oct; 19(3):222-6. PubMed ID: 7528758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T cell response to hepatitis B and C: from viral elimination to hepatocellular carcinoma].
    Thimme R; Spangenberg HC; Von Weizsäcker F; Blum HE
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2277-9. PubMed ID: 12397543
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.
    Kong J; Diao Z; Deng X; Zhong H; Yao W; Hu X
    Oncol Rep; 2007 Jul; 18(1):279-85. PubMed ID: 17549380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell recognition of hepatitis B and C viral antigens.
    Jung MC; Diepolder HM; Pape GR
    Eur J Clin Invest; 1994 Oct; 24(10):641-50. PubMed ID: 7531642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-A, B, C, DR and DQ expression and hepatocellular carcinoma: study of 205 Italian subjects.
    Ricci G; Colombo C; Ghiazza B; Porta C; Moroni M; Illeni MT
    Cancer Lett; 1995 Nov; 98(1):121-5. PubMed ID: 8529200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
    Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
    World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of epidemiological evidence for a role of resolved hepatitis B virus infection in hepatocarcinogenesis in patients infected with hepatitis C virus in Japan.
    Hiraoka T; Katayama K; Tanaka J; Ohno N; Joko K; Komiya Y; Kumagai J; Mizui M; Hino K; Miyakawa Y; Yoshizawa H
    Intervirology; 2003; 46(3):171-6. PubMed ID: 12867755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.
    Kakumu S; Ito S; Ishikawa T; Mita Y; Tagaya T; Fukuzawa Y; Yoshioka K
    J Gastroenterol Hepatol; 2000 Apr; 15(4):431-6. PubMed ID: 10824889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
    Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
    J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses.
    Kato Y; Nakata K; Omagari K; Furukawa R; Kusumoto Y; Mori I; Tajima H; Tanioka H; Yano M; Nagataki S
    Cancer; 1994 Oct; 74(8):2234-8. PubMed ID: 7922974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased infiltration of regulatory T cells in hepatocellular carcinoma of patients with hepatitis B virus pre-S2 mutant.
    Teng CF; Li TC; Wang T; Liao DC; Wen YH; Wu TH; Wang J; Wu HC; Shyu WC; Su IJ; Jeng LB
    Sci Rep; 2021 Jan; 11(1):1136. PubMed ID: 33441885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
    Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
    Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.
    Yutani S; Ueshima K; Abe K; Ishiguro A; Eguchi J; Matsueda S; Komatsu N; Shichijo S; Yamada A; Itoh K; Sasada T; Kudo M; Noguchi M
    J Immunol Res; 2015; 2015():473909. PubMed ID: 26539554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
    Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
    Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.